News Releases

Filter News Releases by year:
2024 | 2023 | 2022 | 2021 | 2020

3 Results

November 2022

NIH Awards $12 Million for Antiviral Therapeutic Development

November 21, 2022

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, recently awarded more than $12 million to three institutions for the development of antiviral therapies to treat diseases caused by viruses with pandemic potential. NIAID may award approximately $61.5 million total over five years if all contract options are exercised.

May 2022

NIAID Announces Antiviral Drug Development Awards

May 18, 2022

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $577 million to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern. 

June 2021

Biden Administration to Invest $3 Billion from American Rescue Plan as Part of COVID-19 Antiviral Development Strategy

June 17, 2021

Through collaboration within the HHS, including NIH, NIAID, and BARDA, the Antiviral Program for Pandemics will respond to the urgent need for antivirals to treat COVID-19.